Cite Filings / PALX / 0001493152-25-017262

Feed Companies Filings Check

Sign in

SCHEDULE 13D

Beneficial Ownership Report

Palomino Laboratories Inc. Filed 2025-10-07 Acc 0001493152-25-017262

Documents 1

SCHEDULE 13D Beneficial Ownership Report , xslSCHEDULE_13D_X01/primary_doc.xml

Around this filing

2025-10-09 4 Director acquired 1,625,000 shares (other)
2025-10-09 4 Chief Accounting Officer acquired 83,334 shares (other)
2025-10-08 SCHEDULE 13D Beneficial Ownership Report
2025-10-07 SCHEDULE 13D Beneficial Ownership Report
2025-10-06 8-K Material agreement · Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change
2025-10-06 SCHEDULE 13D/A Beneficial Ownership Report
2025-10-06 SCHEDULE 13D Beneficial Ownership Report

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13D_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…